Methotrexate-Induced Pneumonitis in Rheumatoid Arthritis Long-term Treatment With Tofacitinib Therapy

被引：1
作者：
Vinicki, Juan Pablo [2 ]
Papagno, Maria Julia [1 ]
Estevez, Adrian Jorge [1 ]
机构：
[1] Hosp El Cruce, Serv Reumatol, Buenos Aires, DF, Argentina
[2] Hosp Quilmes, Unidad Reumatol, Buenos Aires, DF, Argentina
来源：
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY | 2021年 / 27卷 / 8S期
关键词：
INTERSTITIAL LUNG-DISEASE; RISK-FACTORS; MULTICENTER; ABATACEPT;
D O I：
10.1097/RHU.0000000000001336
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S426 / S427
页数：2
相关论文
共 15 条
  • [1] Risk factors for methotrexate-induced lung injury in patients with rheumatoid arthritis - A multicenter, case-control study
    Alarcon, GS
    Kremer, JM
    Macaluso, M
    Weinblatt, ME
    Cannon, GW
    Palmer, WR
    StClair, EW
    Sundy, JS
    Alexander, RW
    Smith, GJW
    Axiotis, CA
    [J]. ANNALS OF INTERNAL MEDICINE, 1997, 127 (05) : 356 - +
  • [2] CARROLL GJ, 1994, J RHEUMATOL, V21, P51
  • [3] Clinical expression of leflunomide-induced pneumonitis
    Chikura, Batsi
    Lane, Steven
    Dawson, Julie K.
    [J]. RHEUMATOLOGY, 2009, 48 (09) : 1065 - 1068
  • [4] Abatacept in patients with rheumatoid arthritis and interstitial lung disease: A national multicenter study of 63 patients
    Fernandez-Diaz, Carlos
    Loricera, Javier
    Castaneda, Santos
    Lopez-Mejias, Raquel
    Ojeda-Garcia, Clara
    Olive, Alejandro
    Rodriguez-Muguruza, Samantha
    Carreira, Patricia E.
    Perez-Sandoval, Trinidad
    Retuerto, Miriam
    Cervantes-Perez, Evelin C.
    Flores-Robles, Bryan J.
    Hernandez-Cruz, Blanca
    Urruticoechea, Ana
    Maiz-Alonso, Olga
    Arboleya, Luis
    Bonilla, Gema
    Hernandez-Rodriguez, Inigo
    Palma, Desiree
    Delgado, Concepcion
    Exposito-Molinero, Rosa
    Ruibal-Escribano, Ana
    Alvarez-Rodriguez, Belen
    Blanco-Madrigal, Juan
    Bernal, Jose A.
    Vela-Casasempere, Paloma
    Rodriguez-Gomez, Manuel
    Fito, Concepcion
    Ortiz-Sanjuan, Francisco
    Narvaez, Javier
    Moreno, Manuel
    Lopez-Corbeto, Mireia
    Mena-Vazquez, Natalia
    Aguilera-Cros, Clara
    Romero-Yuste, Susana
    Ordonez, Sergi
    Villa-Blanco, Ignacio
    Carmen Gonzelez-Vela, M.
    Mora-Cuesta, Victor
    Palmou-Fontana, Natalia
    Hernandez, Jose L.
    Gonzalez-Gay, Miguel A.
    Blanco, Ricardo
    [J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 2018, 48 (01) : 22 - 27
  • [5] HLA-A*31:01 and methotrexate-induced interstitial lung disease in Japanese rheumatoid arthritis patients: a multidrug hypersensitivity marker?
    Furukawa, Hiroshi
    Oka, Shomi
    Shimada, Kota
    Tsuchiya, Naoyuki
    Tohma, Shigeto
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 (01) : 153 - 155
  • [6] Risk of interstitial lung disease associated with leflunomide treatment in Korean patients with rheumatoid arthritis
    Ju, Ji Hyeon
    Kim, Sung-Il
    Lee, Jun-Hee
    Lee, Sang-Il
    Yoo, Wan-Hee
    Choe, Jung-Yoon
    Chung, Seung-Hie
    Lee, Jisoo
    Lee, You-Hyun
    Lee, Shin-Seok
    Yoon, Hyun-Jung
    Yoon, Chong-Hyeon
    Mm, Ho-Youn
    Park, Sur G-Hwan
    [J]. ARTHRITIS AND RHEUMATISM, 2007, 56 (06): : 2094 - 2096
  • [7] The treatment of inflammatory arthritis with methotrexate in clinical practice: treatment duration and incidence of adverse drug reactions
    Kinder, AJ
    Hassell, AB
    Brand, J
    Brownfield, A
    Grove, M
    Shadforth, MF
    [J]. RHEUMATOLOGY, 2005, 44 (01) : 61 - 66
  • [8] Tofacitinib for refractory interstitial lung diseases in anti-melanoma differentiation-associated 5 gene antibody-positive dermatomyositis
    Kurasawa, Kazuhiro
    Arai, Satoko
    Namiki, Yumeko
    Tanaka, Ayae
    Takamura, Yuta
    Owada, Takayoshi
    Arima, Masafumi
    Maezawa, Reika
    [J]. RHEUMATOLOGY, 2018, 57 (12) : 2114 - 2119
  • [9] Abatacept Therapy in Rheumatoid Arthritis With Interstitial Lung Disease
    Mera-Varela, Antonio
    Perez-Pampin, Eva
    [J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2014, 20 (08) : 445 - 446
  • [10] Pfizer, JAP PACK INS TOF
12